BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

249 related articles for article (PubMed ID: 8486477)

  • 21. [Long-term management of patients with chronic renal failure].
    Brunner FP
    Schweiz Med Wochenschr; 1989 Jul; 119(26):950-6. PubMed ID: 2678434
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Antihypertensive agents and renal protection: calcium channel blockers.
    Saruta T; Kanno Y; Hayashi K; Konishi K
    Kidney Int Suppl; 1996 Jun; 55():S52-6. PubMed ID: 8743511
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Progression of renal disease--can it be reversed? The role of calcium channel blockers and angiotensin-converting enzyme inhibitors.
    Boner G
    Isr J Med Sci; 1996 Dec; 32(12):1217-21. PubMed ID: 9007157
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Management of hypertension in chronic renal failure.
    Maiorca R; Scolari F; Cancarini G; Brunori G; Camerini C
    Contrib Nephrol; 1987; 54():190-201. PubMed ID: 2882951
    [No Abstract]   [Full Text] [Related]  

  • 25. [Use of angiotensin converting enzyme inhibitors in nephrology].
    Stefanović V; Ivić M; Bogićević M
    Srp Arh Celok Lek; 1994; 122(7-8):228-30. PubMed ID: 17974394
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Etiology and therapy of chronic primary glomerulonephritis].
    Dohi K; Kanauchi M
    Nihon Naika Gakkai Zasshi; 1998 Jul; 87(7):1271-6. PubMed ID: 9745275
    [No Abstract]   [Full Text] [Related]  

  • 27. [Progressive renal failure. Why blood pressure must now be monitored].
    Tepel M; van der Giet M; Zidek W
    MMW Fortschr Med; 2000 Jun; 142(25):42-4. PubMed ID: 10920669
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Difficult therapy in patients with renal failure. What protects, what damages the kidneys?].
    Stiefelhagen P
    MMW Fortschr Med; 2005 Apr; 147(16):4-6. PubMed ID: 16392389
    [No Abstract]   [Full Text] [Related]  

  • 29. The CARI guidelines. Prevention of progression of kidney disease.
    Harris D; Thomas M; Johnson D; Nicholls K; Gillin A;
    Nephrology (Carlton); 2006 Apr; 11 Suppl 1():S2-197. PubMed ID: 16684077
    [No Abstract]   [Full Text] [Related]  

  • 30. [Recent advances in therapy for chronic glomerular diseases].
    Nitta K
    Nihon Rinsho; 2006 Feb; 64 Suppl 2():385-93. PubMed ID: 16523920
    [No Abstract]   [Full Text] [Related]  

  • 31. Effect of ACE inhibitors, calcium channel blockers and their combination on renal and extrarenal structures in renal failure.
    Amann K; Törnig J; Nichols C; Zeier M; Mall G; Ritz E
    Nephrol Dial Transplant; 1995 Oct; 10 Suppl 9():33-8. PubMed ID: 8643206
    [No Abstract]   [Full Text] [Related]  

  • 32. Renal protection in essential hypertension: how do angiotensin-converting enzyme inhibitors compare with calcium antagonists?
    Bauer JH; Reams GP
    J Am Soc Nephrol; 1990 Nov; 1(5 Suppl 2):S80-7. PubMed ID: 16989071
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Systemic hypertension and antihypertensive agents.
    Maschio G; Marcantoni C; Bernich P
    J Nephrol; 1999; 12 Suppl 2():S100-4. PubMed ID: 10688408
    [No Abstract]   [Full Text] [Related]  

  • 34. Comparison of the effects of ACE inhibitors and calcium channel blockers on the progression of renal failure.
    Zucchelli P; Zuccalà A; Gaggi R
    Nephrol Dial Transplant; 1995 Oct; 10 Suppl 9():46-51. PubMed ID: 8643208
    [No Abstract]   [Full Text] [Related]  

  • 35. [ACE inhibitors in kidney diseases--only another antihypertensive agent?].
    Ritz E; Stein G
    Med Klin (Munich); 1994 Sep; 89(9):473-5. PubMed ID: 7968882
    [No Abstract]   [Full Text] [Related]  

  • 36. [Progression of chronic renal insufficiency].
    Rossert J; Fischer E; Venetz JP
    Nephrologie; 1999; 20(1):3-7. PubMed ID: 10081030
    [No Abstract]   [Full Text] [Related]  

  • 37. [Modes of clinical presentation of glomerular diseases].
    Dervaux T; Moulin B
    Rev Prat; 2003 Nov; 53(18):2013-21. PubMed ID: 15008215
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Secondary hypertension due to glomerulonephritis].
    Azuma T; Nakagawa S
    Nihon Rinsho; 1992 May; 50 Suppl():579-85. PubMed ID: 1355138
    [No Abstract]   [Full Text] [Related]  

  • 39. A randomized and double-blind comparison of isradipine and spirapril as monotherapy and in combination on the decline in renal function in patients with chronic renal failure and hypertension.
    Petersen LJ; Petersen JR; Talleruphuus U; Møller ML; Ladefoged SD; Mehlsen J; Jensen HA
    Clin Nephrol; 2001 May; 55(5):375-83. PubMed ID: 11393383
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Blood pressure and progression of renal failure in the elderly.
    Acone D; Cante D; Cillo F; Giordano G; Giordano C
    Kidney Int Suppl; 1996 Jun; 55():S75-7. PubMed ID: 8743516
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.